Sinovac Biotech Ltd
NASDAQ:SVA

Watchlist Manager
Sinovac Biotech Ltd Logo
Sinovac Biotech Ltd
NASDAQ:SVA
Watchlist
Price: 6.47 USD Market Closed
Market Cap: 644.7m USD

Wall Street
Price Targets

SVA Price Targets Summary
Sinovac Biotech Ltd

There are no price targets for SVA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sinovac Biotech Ltd Competitors:
Price Targets
RCKT
Rocket Pharmaceuticals Inc
130% Upside
IKT
Inhibikase Therapeutics Inc
396% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
33% Upside
COV
Covalon Technologies Ltd
96% Upside
251120
Bio-FD&C Co Ltd
18% Upside
CUV
Clinuvel Pharmaceuticals Ltd
102% Upside
ATRA
Atara Biotherapeutics Inc
15% Upside
LVTX
LAVA Therapeutics NV
20% Downside

Revenue
Forecast

Revenue Estimate
Sinovac Biotech Ltd

For the last 12 years the compound annual growth rate for Sinovac Biotech Ltd's revenue is 19%. The projected CAGR for the next 9 years is -20%.

19%
Past Growth
-20%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Sinovac Biotech Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Sinovac Biotech Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SVA's stock price target?
Not Available

SVA doesn't have any price targets made by Wall Street professionals.

What is Sinovac Biotech Ltd's Revenue forecast?
Projected CAGR
-20%

For the last 12 years the compound annual growth rate for Sinovac Biotech Ltd's revenue is 19%. The projected CAGR for the next 9 years is -20%.

Back to Top